Men should talk to their doctor about the risks and benefits of getting screened for the disease, advised Dr. Alexander Kutikov, chief of the division
of urologic oncology at Fox Chase in Philadelphia.
Our 2nd International Prostate Cancer Symposium and Inaugural World Congress
of Urologic Oncology at The Mount Sinai Hospital
Dr. Kauffman is a member of the American Urological Association and the Society
of Urologic Oncology.
In this Father's Day Edition of the Breeze Knows, Anita Velardo talks with Dr. Isaac Kim, Director
of the Urologic Oncology Program at the Cancer Institute of New Jersey and assistant professor of surgery at UMDNJ - Robert Wood Johnson Medical School.
Dr. Isaac Kim, Chief
of Urologic Oncology, has also developed a new surgical technique for nerve sparing (Athermal Intrafascial Robotic Prostatectomy or AIR prostatectomy) using the robot that leads to faster recovery of sexual function as well as bladder control.
«Instead of administering a cancer vaccine to destroy tumors, we hope to modify the immune system to allow the patient's own tumor to act as a cancer vaccine,» said Hyung Lae Kim, MD, co-medical director
of the Urologic Oncology Program and lead author of the study.
Results of the work are being presented at the 2017 Genitourinary Cancers Symposium (co-sponsored by the American Society of Clinical Oncology, American Society for Radiation Oncology and the Society
of Urologic Oncology) in Orlando later this week.
The study of 1,003 men was conducted at the NIH in Bethesda, Md., from 2007 - 2014, with Peter A. Pinto, MD, the head of the prostate cancer section
of the urologic oncology branch, serving as the senior investigator.
Not exact matches
«The results
of the phase III clinical trial show that a target fusion biopsy detects more clinically significant prostate cancer,» said Art Rastinehad, DO, principal investigator
of the study and director
of interventonal
urologic oncology at North Shore - LIJ's Arthur Smith Institute for Urology, in New Hyde Park, NY.
The study, presented by Jeffrey Bassett, M.D., MPH, fellow in
Urologic Oncology, and Principal Investigator Daniel Barocas, M.D., MPH, assistant professor
of Urologic Surgery, was shared during the American Urological Association (AUA) annual conference held May 16 — 21 in Orlando, Florida, and was highlighted during the AUA press program.
Since completing my
urologic oncology fellowship at Memorial Sloan - Kettering Cancer Center in 2008, I have spent most
of my career at the Rutgers Cancer Institute
of New Jersey.
He completed a clinical and research fellowship in
Urologic Oncology at the National Cancer Institute
of the National Institutes
of Health in Bethesda, MD in 2012.